Reply to Pesko et al
Clin Infect Dis
.
2022 Nov 30;75(11):2050.
doi: 10.1093/cid/ciac589.
Authors
Ronza Najjar-Debbiny
1
2
,
Naomi Gronich
2
3
,
Gabriel Weber
2
4
,
Johad Khoury
5
6
,
Lee Hilary Goldstein
2
7
8
,
Walid Saliba
2
3
9
Affiliations
1
Infection Control and Prevention Unit, Lady Davis Carmel Medical Center, Haifa, Israel.
2
Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
3
Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.
4
Infectious Diseases Unit, Lady Davis Carmel Medical Center, Haifa, Israel.
5
Pulmonology Division, Lady Davis Carmel Medical Center, Haifa, Israel.
6
Pulmonology, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
7
Internal Medicine C, Emek Medical Center, Afula, Israel.
8
Clinical Pharmacology Unit, Emek Medical Center, Afula, Israel.
9
Translational Epidemiology Unit and Research Authority, Lady Davis Carmel Medical Center, Haifa, Israel.
PMID:
35869851
DOI:
10.1093/cid/ciac589
No abstract available
Publication types
Letter
Comment